Lowe Wealth Advisors’s Moderna MRNA Stock Holding History

Lowe Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.36K	Hold	130	–	–	﹤0.01%	314
2025 Q2	$3.59K	Hold	130	–	–	﹤0.01%	310
2025 Q1	$3.69K	Hold	130	–	–	﹤0.01%	308
2024 Q4	$5.41K	Hold	130	–	–	﹤0.01%	267
2024 Q3	$8.69K	Hold	130	–	–	﹤0.01%	229
2024 Q2	$15.4K	Hold	130	–	–	0.01%	190
2024 Q1	$13.9K	Hold	130	–	–	0.01%	194
2023 Q4	$12.9K	Hold	130	–	–	0.01%	194
2023 Q3	$13.4K	Hold	130	–	–	0.01%	179
2023 Q2	$15.8K	Hold	130	–	–	0.01%	180
2023 Q1	$20K	Sell	130 -33	-20%	-$5.44K	0.01%	149
2022 Q4	$29.3K	Hold	163	–	–	0.02%	134
2022 Q3	$19K	Hold	163	–	–	0.01%	152
2022 Q2	$23K	Hold	163	–	–	0.01%	133
2022 Q1	$28K	Hold	163	–	–	0.01%	131
2021 Q4	$41K	Buy	+163	New	+$47.7K	0.02%	111

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Lowe Wealth Advisors's MRNA Position: Q3 2025 in Review

Lowe Wealth Advisors held its Moderna (MRNA) position steady in Q3 2025 at 130 shares worth $3.36K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Lowe Wealth Advisors first reported a position in MRNA in Q4 2021 and has held it in 16 quarters since. The position peaked at $41K in Q4 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

Lowe Wealth Advisors held 130 shares of Moderna worth $3.36K as of Q3 2025.
Lowe Wealth Advisors left its Moderna share count unchanged in Q3 2025.
Moderna made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #314 holding.
Lowe Wealth Advisors first reported a position in Moderna in Q4 2021 and has held it in 16 quarters since.
Lowe Wealth Advisors's Moderna position peaked at $41K in Q4 2021.
643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.